0001209191-19-053543.txt : 20191017
0001209191-19-053543.hdr.sgml : 20191017
20191017202332
ACCESSION NUMBER: 0001209191-19-053543
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191016
FILED AS OF DATE: 20191017
DATE AS OF CHANGE: 20191017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mamluk Roni
CENTRAL INDEX KEY: 0001647053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37500
FILM NUMBER: 191156493
MAIL ADDRESS:
STREET 1: CHIASMA, INC.
STREET 2: 60WELLS AVENUE
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIASMA, INC
CENTRAL INDEX KEY: 0001339469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 460 TOTTEN POND ROAD
STREET 2: SUITE 530
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-928-5300
MAIL ADDRESS:
STREET 1: 460 TOTTEN POND ROAD
STREET 2: SUITE 530
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: CHIASMA INC
DATE OF NAME CHANGE: 20050922
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-16
0
0001339469
CHIASMA, INC
CHMA
0001647053
Mamluk Roni
C/O CHIASMA, INC.
460 TOTTEN POND ROAD, SUITE 530
WALTHAM
MA
02451
1
0
0
0
Common Stock
2019-10-16
4
M
0
10000
0.09
A
10000
D
Common Stock
2019-10-16
4
S
0
10000
4.94
D
0
D
Stock Option (Right to Buy)
0.09
2019-10-16
4
M
0
10000
0.00
D
2021-09-20
Common Stock
10000
61139
D
The sale was effected pursuant to a Rule 10b5-1 trading plan dated November 19, 2018 adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.78 to $5.00, inclusive. The reporting person undertakes to provide to Chiasma, Inc., any security holder of Chiasma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This option is fully vested and exercisable.
/s/ Mark J. Fitzpatrick, Attorney-in-Fact
2019-10-17